# Fluticasone + Vilanterol

## Relvar Ellipta 92/22mcg inhalation powder

##### 

| 藥品代碼   | ERELV                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Asthma: Treatment of asthma in patients >=18 years. Chronic obstructive pulmonary disease: Maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD)， including chronic bronchitis and/or emphysema; to reduce exacerbations of COPD in patients with a history of exacerbations Fluticasone 100 mcg/vilanterol 25 mcg is the only strength indicated for the treatment of COPD.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 用法用量   | One inhalation of Relvar Ellipta 92/22 micrograms once daily. (maximum dose: 1 inhalation/day)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 禁忌       | Hypersensitivity to fluticasone， vilanterol or any component of the formulation; severe hypersensitivity to milk proteins; primary treatment of status asthmaticus or other acute episodes of COPD or asthma where intensive measures are required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 副作用     | 1% to 10%: Cardiovascular: Hypertension (>3%)， peripheral edema (>3%)， extrasystoles (>2%)， supraventricular extrasystole (>2%)， ventricular premature contractions (>2%) Central nervous system: Headache (5% to 8%) Gastrointestinal: Oropharyngeal candidiasis (2% to 5%)， diarrhea (>3%)， upper abdominal pain (>2%) Infection: Influenza (>3%) Neuromuscular & skeletal: Arthralgia (2% to >3%)， back pain (2% to >3%)， bone fracture (2%) Respiratory: Nasopharyngitis (6% to 10%)， upper respiratory tract infection (>2% to 7%)， pneumonia (2% to 7%)， oropharyngeal pain (2% to ?3%)， pharyngitis (2% to ?3%)， chronic obstructive pulmonary disease (?3%)， cough (1% to 3%)， sinusitis (1% to 3%)， bronchitis (3%)， acute sinusitis (2%)， allergic rhinitis (2%)， rhinitis (2%)， viral respiratory tract infection (2%)， voice disorder (2%) Miscellaneous: Fever (2% to 3%) <1%， postmarketing， and/or case reports: Anaphylaxis， angioedema， cataract， glaucoma， hypersensitivity reaction， muscle spasm， nervousness， palpitations， paradoxical bronchospasm， skin rash， tachycardia， tremor， urticaria |
| 孕期建議   | Uknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 哺乳期建議 | Unknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

